• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2017

View Archived Issues

Lundbeck recaps progress of fourth quarter 2016

Read More

ASLAN Pharmaceuticals presents phase II results for varlitinib

Read More

Treatment with MD-1003 shows efficacy and safety in patients with progressive multiple sclerosis

Read More

Promising inhibitors of STOML3 oligomerization in treating tactile-driven pain following neuropathy

Read More

Kagoshima University identifies novel anti-hepatitis B virus agents

Read More

Neurocrine and Bial sign licensing agreement for opicapone in U.S. and Canada

Read More

SC-83288, a clinical development candidate with novel mode of action for the treatment of malaria

Read More

Update on phase III trials of NC-6004 for the treatment of pancreatic cancer

Read More

CEVEC Pharmaceuticals signs agreement with NewLink Genetics for use of its cell lines

Read More

Phase I results show UE-2343 is brain penetrant and well tolerated

Read More

Armetheon agrees with FDA on phase III study for oral anticoagulant

Read More

Tracon reports phase II topline results for TRC-105 in recurrent glioblastoma

Read More

Marathon Pharmaceuticals' Emflaza approved by FDA for DMD

Read More

Viking Therapeutics reports results on VK-2809 in model of GSD Ia

Read More

MRC, South African MRC and GSK partner to tackle noncommunicable diseases in Africa

Read More

MediWound reports favorable results from phase II study of NexoBrid

Read More

Ovid Therapeutics enters Angelman syndrome biomarker collaboration, begins phase II study

Read More

Tessa Therapeutics and A*STAR's IMCB collaborate on immuno-oncology lab

Read More

Copanlisib named FDA orphan drug for splenic, nodal and extranodal marginal zone lymphoma

Read More

FDA names laquinimod sodium an orphan drug for Huntington's disease

Read More

Generex continues process to acquire controlling equity interest in Emmaus Life Sciences

Read More

U.S. orphan drug designation granted to IMG-7289 for acute myeloid leukemia

Read More

Blood NF-L, a promising biomarker for differential diagnosis of parkinsonian disorder

Read More

Systems Oncology signs license agreement with University of Wisconsin-Milwaukee

Read More

Prevacus plans phase I studies of PRV-002 to treat concussion

Read More

Boehringer Ingelheim starts phase II trial to treat advanced squamous cell carcinoma of the lung

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe